https://doi.org/10.1038/bcj.2015.102
N
Nader Omidvar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
1.3K
Citations
16
h-index
19
i10-index
Nader Omidvar is an academic researcher from Iran University of Medical Sciences. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Protein Degradation and Inhibitors. The author has an h-index of 16, co-authored 73 publications.
Papers by this author
workspVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice
2015 · Blood Cancer Journal · 2 citations
Additional file 2: Figure S1. of GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3646526_d2
Additional file 2: Figure S1. of GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3646526_d1
Supplementary Material for: Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11999943
Additional file 1: of GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3646526_d3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat